Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. NUTX
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
NUTX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

NUTX Similar Chart Price Prediction

The price of NUTX is predicted to go up 8.97%, based on the high correlation periods with LFVN. The similarity of these two price pattern on the periods is 98.88%.

stocks logo

NUTX

stocks logo

LFVN

Up: 8.97%Similarity: 98.88%

NUTX Revenue Forecast

NUTX EPS Forecast

NUTX FAQs

What is bull’s view on NUTX?

Maxim Group projects an 83.23% upside for Nutex Health (NUTX), with a one-year price target of $45.90, citing strong revenue growth and institutional ownership increases. Benchmark raised its target to $60, highlighting revenue and EBITDA growth alongside strategic initiatives to boost patient volumes. Despite recent EPS misses, Nutex's revenue beats and growth potential make it attractive for bullish investors.

What is bear's view on NUTX?

NUTX stock is bearish due to its weak financial performance and valuation concerns. The company reported a Q2 2024 EPS of -$0.07, missing estimates, and its revenue growth is insufficient to offset losses. With a recent close at $47.63 and limited upside potential, the stock faces resistance near $49.

What is NUTX revenue forecast for next quarter？

The market consensus for NUTX's revenue in the upcoming quarter is projected to be approximately $81.828M USD.

NUTX VS S&P500

Ask Intellectia about NUTX

NUTX Analyst's Forecast

Anthony Vendetti

Maxim Group

Strong Buy

2024-11-12

Price Target

$45 → $50

Upside

+33.12%

Maxim raised the firm's price target on Nutex Health to $50 from $45 and keeps a Buy rating on the shares. The company's Q3 results topped estimates, with positive trends in metrics fueling its growth, the analyst tells investors in a research note. Maxim adds that the firm expects Nutex to generate $8.9M in operating cash per quarter through 2025 and believes that the company has sufficient capital to maintain current operations, even though it may raise capital to accelerate new hospital openings.
Bill Sutherland

Benchmark

Strong Buy

2024-11-12

Price Target

$45 → $60

Upside

+59.74%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

ASGN

ASGN Inc

$67.99
-2.10%
stocks logo

MIR

Mirion Technologies Inc

$14.96
-1.77%
stocks logo

BHVN

Biohaven Ltd

$36.54
-1.72%
stocks logo

COMP

Compass Inc

$9.01
-4.66%
stocks logo

SG

Sweetgreen Inc

$23.15
0.04%
stocks logo

FRO

Frontline Plc

$15.31
-4.13%
stocks logo

PJT

PJT Partners Inc

$157.35
-1.14%
stocks logo

ADMA

ADMA Biologics Inc

$15.44
-2.15%
stocks logo

FULT

Fulton Financial Corp

$19.53
-0.71%
stocks logo

NCNO

nCino Inc

$30.76
-1.13%